Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2018	Mar. 31, 2017
Cash flows from operating activities:
Net income (loss) attributable to common shareholders		$ 2,657,245	$ (1,973,401)
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments		17,036	84,656
Realized investment gains, net		(534,242)	498,691
Change in fair value of equity securities	[1]	(4,129,236)	0
Unrealized trading (gains) losses included in income		0	111,531
Realized trading (gains) losses included in income		0	(110,470)
Amortization of cost of insurance acquired		201,516	209,776
Depreciation		275,143	175,471
Net income attributable to noncontrolling interest		29,500	(141,234)
Charges for mortality and administration of universal life and annuity products		(1,650,201)	(1,661,871)
Interest credited to account balances		883,563	1,092,176
Change in accrued investment income		(357,576)	(191,914)
Change in reinsurance receivables		35,546	320,738
Change in policy liabilities and accruals		(6,961)	3,707
Change in income taxes receivable (payable)		12,974	44,380
Change in other assets and liabilities, net		5,894,257	(1,038,724)
Net cash used in operating activities		3,328,564	(2,576,488)
Proceeds from investments sold and matured:
Fixed maturities available for sale		14,515	2,614,087
Equity securities		103,298	0
Mortgage loans		2,009,715	290,019
Real estate		7,941,649	875,507
Notes receivable		563,926	99,787
Policy loans		366,847	528,338
Short term investment		850,000	0
Total proceeds from investments sold and matured		11,849,950	4,407,738
Cost of investments acquired:
Fixed maturities available for sale		(4,971,517)	(1,977,627)
Equity securities		(7,957,471)	(2,099,959)
Mortgage loans		0	(333,581)
Real estate		(6,006,130)	(446,391)
Notes receivable		0	(547,853)
Policy loans		(405,337)	(351,267)
Short-term investments		(850,000)	0
Total cost of investments acquired		(20,190,455)	(5,756,678)
Net cash provided by investing activities		(8,340,505)	(1,348,940)
Cash flows from financing activities:
Policyholder contract deposits		1,149,533	1,242,214
Policyholder contract withdrawals		(1,245,743)	(1,212,530)
Purchase of treasury stock		(600,240)	(26,285)
Issuance of stock		230,000	197,488
Non controlling contributions (distributions) of consolidated subsidiary		(146)	8,089
Net cash used in financing activities		(466,596)	208,976
Net increase in cash and cash equivalents		(5,478,537)	(3,716,452)
Net increase (decrease) in cash and cash equivalents		25,434,199	15,156,548
Cash and cash equivalents at end of year		$ 19,955,662	$ 11,440,096

[1] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 2.